Mangaluru: After CFI protest, Srinivas College assures to repeal hijab ban

Bengaluru, Jan 4: Kannada star Dr Shivarajkumar, son of Kannada film legend Dr Rajkumar, has been discharged from the hospital in Miami, US, following complete recovery from cancer, family sources confirmed on Saturday.

Nivedita, Shivarajkumar’s daughter, has shared a picture showing the actor and family in a relaxed mode. Sources further stated that Shivarajkumar will be in the US for follow-ups and resting for one month and he will be back for the shooting by Feb first or the second week.

Shivarajkumar is expected to begin shooting of the Telugu superstar Ramcharan-starrer pan India movie soon. 

Earlier, Shivarajkumar shared a video from the US on the first day of 2025, detailing his journey of overcoming cancer and assuring fans of his return.

In the video, he conveyed his New Year wishes to everyone and said, “I am hesitant to speak as I might get emotional at this moment. Leaving Karnataka was a very emotional experience for me. Under these circumstances, fear is inevitable, but the support of my fans has significantly reduced it.”

He continued, “The way the doctors took care of me, gave me immense courage. While shooting for the movie ‘45’, I underwent chemotherapy and even filmed the climax fight scene. As the date to leave for the US for treatment approached, I became anxious. However, my wife Geetha and daughter Nivedita stood by me throughout.”

“Dr Manohar, who treated me, cared for me like a child. My urinary bladder has been replaced, but there is no need for anyone to panic. I am doing well and will be back with double the energy. I thank all my fans for their unwavering support,” Shivarajkumar assured.

Geetha Shivarajkumar, his wife, who had appeared in the video alongside him, stated that all the medical reports had come back negative, and it was officially declared that Shivarajkumar is cancer-free. “He recovered because of the blessings of his fans, and I will never forget this,” she said.

The actor underwent surgery at a hospital in Miami, US, where his cancerous bladder was removed. According to the surgeon, Dr Murugesh Manoharan, an artificial bladder was created using Shivarajkumar’s intestine.

In November, Shivarajkumar had spoken publicly about his illness, acknowledging that he was human like everyone else. While he didn’t disclose it was cancer at the time, he said, “At the end of the day, I am a human being. I have a health issue and am currently undergoing treatment for it. I have completed a couple of treatment sessions, and a few more are pending. After that, I will undergo surgery, either in India or the US.”

Two cases of Human Metapneumovirus (HMPV) were reported in Bengaluru on January 6 - a 3-month-old baby who has been discharged and an 8-month-old who is recovering at a hospital in the Karnataka capital. This marks the first reported cases of HMPV in India.

The infected infants and their families have no recent travel history, ruling out exposure from other regions or countries, the health department said.

HMPV is a respiratory virus that often causes mild symptoms resembling a cold but can lead to other complications, particularly in infants, the elderly, and those with weakened immune systems. The virus can occasionally trigger pneumonia or exacerbate chronic respiratory conditions. Cases typically rise during the winter and early spring.

The Centre announced on Sunday that it is monitoring HMPV and other respiratory viruses, especially following recent reports of increased respiratory illnesses in China. A Joint Monitoring Group (JMG) convened on January 4 to evaluate the situation, with representatives from the World Health Organisation (WHO), National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), and other health organisations participating.

Respiratory illnesses in China align with seasonal variations caused by viruses such as influenza, RSV, and HMPV. Current surveillance data from India does not indicate any unusual surge in respiratory infections, according to the Ministry of Health and Family Welfare.

As a precaution, the Centre has increased laboratory capacity for HMPV testing. The ICMR will monitor HMPV trends throughout the year, alongside other respiratory illnesses such as influenza-like illness (ILI) and severe acute respiratory infections (SARI). A robust network of surveillance systems, including those operated by ICMR and the Integrated Disease Surveillance Programme (IDSP), continues to track respiratory infections across the country.

Hospitals have been advised to strengthen isolation protocols for suspected cases, ensure the availability of essential medicines, and promptly report ILI and SARI cases through the Integrated Health Information Platform (IHIP).

Precautions to Take:

To reduce the risk of HMPV infection, individuals are advised to:

• Wash hands frequently with soap and water for at least 20 seconds.
• Avoid close contact with people who have respiratory symptoms.
• Wear masks in crowded or high-risk areas, especially during seasonal outbreaks.
• Maintain good indoor ventilation by keeping windows open when possible.
• Disinfect commonly touched surfaces regularly, such as doorknobs, toys, and tables.
• Monitor infants, the elderly, and people with chronic illnesses for symptoms like persistent cough or breathing difficulties.
• Seek prompt medical attention if respiratory symptoms worsen or persist. 

Mangaluru: In a significant development, Mescom has proposed a phased electricity tariff hike starting with Rs 0.70 per unit for the fiscal year 2025-26. The proposal has been submitted to the Karnataka Electricity Regulatory Commission (KERC) for approval, signaling a potential increase in electricity costs for consumers.

Mescom emphasized that the current tariff structure is insufficient to meet operational expenses and manage revenue effectively. To address this, the company has invited public objections to the proposed hike.

Currently, the electricity supply cost is Rs 9.23 per unit, while the consumer tariff stands at Rs 8.53 per unit, leading to a shortfall of Rs 0.70 per unit. For the financial year 2023-24, Mescom reported revenue of Rs 5,924.73 crore against an expenditure of Rs 6,310.39 crore, resulting in a deficit of Rs 367.66 crore. For the 2025-26 fiscal year, projected revenue is Rs 5,850.81 crore, with an actual requirement of Rs 5,961.63 crore, creating a deficit of Rs 110.82 crore.

In a first, Mescom has submitted a multi-year tariff revision proposal to KERC. The plan outlines a hike of Rs 0.70 per unit for 2025-26, followed by Rs 0.37 per unit for 2026-27 and Rs 0.54 per unit for 2027-28.

"An increase in electricity tariff is inevitable," stated Jayakumar R, Managing Director of Mescom. "Mescom has submitted a proposal in this regard to KERC."